-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With funding from the National Natural Science Foundation of China (approval numbers: 81930022, 91749105, 81922017), the Luo Xianghang team at Xiangya Hospital of Central South University has made progress in the research of osteoporosis prevention and treatment
Osteoporosis is a common aging-related bone degenerative disease, which is mainly manifested as a decrease in bone mass accompanied by fat accumulation in the marrow cavity and increased bone fragility
The research team discovered the subgroups of immune-regulated bone senescence and the molecular mechanism of bone senescence, and reported for the first time the mechanism of GCA+ immune cells and GCA’s regulation of bone senescence, and screened out neutralizing antibodies against key immune protein molecules.